- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
-0.06| Last Update: 05/21/13 - 4:04 PM EDT |
| Volume: 3,424,947 |
| YTD Performance: 16.61% |
| Open: $48.09 |
| Previous Close: $48.02 |
| 52 Week Range: $36.91 - $48.40 |
| Oustanding Shares: 341,823,232 |
| Market Cap: 16,335,732,257 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (06/13) | FY (06/14) | |
|---|---|---|---|---|
| Average Estimate | $0.77 | $0.85 | $3.62 | $3.54 |
| Number of Analysts | 8 | 8 | 9 | 10 |
| High Estimate | $0.80 | $0.92 | $3.70 | $3.62 |
| Low Estimate | $0.75 | $0.81 | $3.51 | $3.47 |
| Prior Year | $0.73 | $0.81 | $3.21 | $3.62 |
| Growth Rate (Year over Year) | 5.48% | 4.94% | 12.77% | -2.21% |
Cardinal Health downgraded at CitiCAH was downgraded to Neutral from Buy, said Citigroup. The loss of the contract with Walgreens will limit earnings growth. Price target is $43.
Cardinal Health price target and estimates cut at UBSCAH earnings estimates were reduced, said UBS. The loss of the contract with Walgreens was disappointing and makes the CVS contract renewal even more important. Price target goes to $50.
Cardinal Health downgraded at ISICAH was downgraded from Strong Buy to Buy, ISI Group said. $48.50 price target. Loss of WAG deal will cut into earnings.
Play things close to the vest for now.
Cardinal Health upgraded at MizuhoCAH was upgraded from Neutral to Buy, Mizuho said. $46 price target. Company will likely renew two major contracts in 2013.
Cardinal Health upgraded at ISICAH was upgraded from Market Weight to Overweight, ISI Group said. $46 price target. Stock is already factoring in pricing fears with WAG and CVS.
Cardinal Health numbers cut at Credit SuisseShares of CAH now seen reaching $50, acccording to Credit Suisse. Estimates also reduced, given the company's new guidance. Outperform rating.
Consensus profit forecasts are in jeopardy.